Skip to main content
. 2022 Dec;10(24):1339. doi: 10.21037/atm-22-5668

Figure 3.

Figure 3

Nomogram for classifying IPA and non-IPA patients. FR+CTC, folate-receptor-positive circulating tumor cells; GGO, ground-glass opacity; IPA, invasive pulmonary adenocarcinoma.